Publication: Germs
Abstract
Vancomycin dosing regimens are often based on population data from other regions, and their appropriateness for Indian critically ill patients had not been confirmed. This single-center prospective study in 15 septic ICU patients used a population pharmacokinetic approach with Phoenix NLME to evaluate whether the standard 1 g twice-daily vancomycin regimen achieves the target AUC/MIC ratio of at least 400. Body weight and urinary creatinine clearance were identified as covariates that improved prediction of vancomycin concentrations, and the study concluded that the standard 1 g twice-daily dosing was inappropriate for this population. The findings suggest that incorporating weight and renal function into dosing models could improve vancomycin dosing accuracy in Indian critically ill patients, though further studies are needed to confirm clinical benefit.
Author(s): Belavagi D, Bhandari RK, Shafiq N, Gota V, Patil A, Pandey AK, Mothsara C, Gupta R, Sahni N, Sharma N, Ray P, Kumar V, Sharma SK, Malhotra S
Published: 2022 年 6 月 30 日
Phoenix NLME：Testing a Standard Regimen
Phoenix NLME's population approach found the standard vancomycin regimen falls short for critically ill patients in this Indian ICU study. Phoenix NLME can be paired with Modeling Assistant, an AI copilot for model building and PML authoring, as part of a Phoenix platform that can be extended with third-party tools.
